PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27689933-1	2016	PURPOSE: Directly radioiodinated [131I]-rituximab has been developed as a radioimmunotherapeutic agent in patients with CD20-positive B cell non-Hodgkin"s lymphoma.	Iodine-131	34-38	keratin 20	Homo sapiens	120-124